This inventor holds 1 USPTO granted patent. Top assignees: Lehigh University, Rutgers, The State University of New Jersey, University of Medicine and Dentistry of New Jersey. Active years: 2013.
Company Filing History:
1 out of 183 
1 out of 1,494 
1 out of 272 
Years Active: 2013
Title: The Innovative Contributions of Erik Aponte
Introduction
Erik Aponte is a notable inventor based in Pine Bush, NY (US). He has made significant contributions to the field of pharmacology, particularly through his innovative work on vanilloid compounds. His research focuses on developing treatments for various inflammatory conditions, showcasing his commitment to advancing medical science.
Latest Patents
Erik Aponte holds a patent for "Pharmacologically-active vanilloid carbamates." This application relates to pharmacologically-active vanilloid compounds that are useful for treating various anti-inflammatory states characterized by the inhibition of FAAH. These conditions include Alzheimer's dementia, Parkinson's disease, depression, pain, rheumatoid arthritis, mood disorders, multiple sclerosis, and inflammation. Additionally, his work addresses antagonism of TRPV1, which is relevant for conditions such as Huntington's disease, hypertension, arthritis, allergic airway inflammation, Crohn's disease, ulcerative colitis, and neuropathic pain. He has 1 patent to his name.
Career Highlights
Throughout his career, Erik Aponte has worked with prestigious institutions, including Rutgers, the State University of New Jersey, and the University of Medicine and Dentistry of New Jersey. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to significant advancements in pharmacological research.
Collaborations
Some of Erik Aponte's notable coworkers include Jeffrey D. Laskin and Diane E. Heck. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.
Conclusion
Erik Aponte's work in pharmacologically-active vanilloid compounds highlights his dedication to addressing critical health issues through innovative research. His contributions are paving the way for new treatments that could significantly improve the quality of life for many individuals suffering from inflammatory conditions.